期刊文献+

Trim5α对TAB2诱导的NFκB启动子荧光素酶报告基因活性的影响 被引量:1

Effects of Trim5α on the activation of luciferase reporter gene containing NFκB promoter induced by TAB2
下载PDF
导出
摘要 目的构建人Trim5α的真核表达载体pcDNA3.1(+)-Trim5α,观察其对TAB2诱导的NFκB启动子荧光素酶报告基因活性的影响。方法提取Hela细胞总RNA,用RT-PCR方法扩增出Trim5α基因编码区全长片段,克隆到5`-Flag-pcDNA3.1(+),经酶切、菌落PCR及测序进行鉴定。转染HEK293T细胞,Western blot检测Trim5α蛋白的表达,双萤光素酶报告基因系统检测Trim5α对TAB2诱导的NFκB报告基因活化的影响。结果经鉴定,成功构建Trim5α表达载体,该载体可在HEK293T细胞中表达Trim5α,Trim5α对TAB2诱导的NFκB报告基因活化无显著影响。结论 Trim5α对TAB2诱导的NFκB报告基因活化未见显著影响,初步建立了Trim蛋白对NFκB报告基因影响的功能筛选平台。 We aimed to construct the recombinant eukaryotic expression vector pcDNA3.1(+)-Trim5α and investigate the effects of Trim5α on activation of luciferase reporter gene containing NFκB promoter induced by adaptor proteins TAB2.The total RNA was isolated from Hela cells.The target sequences were amplified with RT-PCR,and then cloned into 5-Flag-pcDNA3.1(+) vector.The recombinant vector was confirmed by restriction enzyme digestion,colony PCR and sequencing,and then was transfected into HEK293T cells to detect Trim5α expression by Western blot.Then,the NFκB activities were determined by dual-luciferase reporter assay.The results of restriction enzyme digestion,colony PCR and sequencing confirmed the vector was constructed successfully,and it expressed Trim5α protein in HEK293T cells.However,dual-luciferase assay showed that Trim5α could not effectively blocks TAB2-induced NFκB activation.In conclusion,Trim5α is not involved in negative regulation of TAB2-induced NFκB activation,thus we preliminarily establish a functional screening platform for Trim protein to evaluate its effects on TAB2-induced NFκB activation.
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第7期580-584,共5页 Immunological Journal
关键词 三基序蛋白5 核因子ΚB 双萤光素酶报告基因系统 Trim5α NFκB Dual-luciferase reporter assay
  • 相关文献

参考文献15

  • 1Reymond A, Meroni G, Fantozzi A, et al. The tripartite motif family identifies cell compartments [I]. EMBO J, 2001, 20(9): 2140-2151.
  • 2Ozato K, Shin DM, Chang TH, et al. TRIM family proteins and their emerging roles in innate immunity[J]. Nat Rev Immunol, 2008, 8(11):849-860.
  • 3Shi M, Deng W, Bi E, et al. TRIM30 alpha negatively regu- lates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation[J]. Nat Immunol, 2008, 9(4): 369-377.
  • 4Hu Y, Mao K, Zeng Y, et al. Tripartite-motif protein 30 neg- atively 1~gulates NLRP3 inflammasome activation by modu- lating reactive oxygen species production [J]. J Immunol, 2010, 185(12):7699-7705.
  • 5Kong H J, Anderson DE, Lee CH, et al. Cutting edge: au- toantigen Ro52 is an interferon inducible E3 ligase that u- biquitinates IRF-8 and enhances cytokine expression in macrophages[J]. J Immunol, 2007, 179(1):26-30.
  • 6Gack MU, Shin YC, Joo CH, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity[J]. Nature, 2007, 446(7138):916-920.
  • 7Uchil PD, Quinlan BD, Chan WT, et al. TRIM E3 ligases in- terfere with early and late stages of the retroviral life cycle[J]. PLoS Pathog, 2008, 4(2):e 16.
  • 8陈聪,姜北,万瑛.模式识别受体视黄酸诱导基因-Ⅰ样受体及信号通路研究进展[J].免疫学杂志,2010,26(7):636-638. 被引量:6
  • 9Carthagena L, Bergamaschi A, Luna JM, et aL Human TRIM gene expression in response to intefferons [J]. PLoS One, 2009, 4(3):e4894.
  • 10Rajsbaum R, Stoye JP, O'Gan'a A. Type I interferon-depen- dent and -independent expression of tripartite motif proteins in immune cells [J]. Eur J Immunol, 2008, 38(3):619-630.

二级参考文献38

  • 1谭艳,陈政良.天然免疫模式识别途径:胞外识别与胞内识别[J].免疫学杂志,2004,20(z1):28-30. 被引量:3
  • 2Beutler B, Rehli M. Evolution of the TIR, tolls and TLRs: functional inferences from computational biology [J]. Curr Top Microhiol Immunol, 2002, 270( 1 ):1-21.
  • 3Parker LC, Prince LR, Sabroe I. Translational mini-review series on Toll-like receptors: networks regulated by Toll-like receptors mediate innate and adaptive immunity[J]. Clin Exp Immunol, 2007, 147(2): 199-207.
  • 4Eisenbarth SC, Flavell RA. Innate instruction of adaptive immunity revisited: the intlammasome [J]. EMBO Mol Med, 2009, 1(2):92-98.
  • 5Loiarro M, Gallo G, Fant N, et al. Identification of critical residues of the MyD88 death domain involved in therecruitment of downstream kinases[J]. J Biol Chem, 2009, 284(41): 28093-28103.
  • 6Jin MS, Kim SE, Heo JY, et al. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acy lated lipopeptide[J]. Cell, 2007, 130(6): 1071-1082.
  • 7Hasan U, Chaffois C, Gaillard C, et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic ceils, which activates gene transcription through MyD88[J]. J Immunol, 2005, 174(5):2942-2950.
  • 8Thompson JM, Iwasaki A. Toll-like receptors regulation of viral infection and disease [J]. Adv Drug Deliv Rev, 2008, 60(7):786-794.
  • 9Andersen-Nissen E, Smith KD, Bonneau R, et al. A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin[J]. J Exp Med, 2007, 204(2):393-403.
  • 10Oliveira M, Gleeson M. The influence of prolonged cycling on monocyte Toll-like receptor 2 and 4 expression in healthymen[J]. Eur J Appl Physiol, 2010, 109(2):251-257.

共引文献57

同被引文献15

  • 1McNab F W, Rajsbaum R, Stoye J P, et al. Tripartite-motif proteins and innate immune regulation. Curr Opin hnmunol, 2011, 23(1) :46-56.
  • 2Niida M, Tanaka M, Kamitani T. Downregulation of active IKK beta by Ro52-mediated autophagy. Mol Immunol, 2010, 47 (14) :2378-2387.
  • 3Shi M, Deng W, Bi E, et al. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat Immunol, 2008, 9(4) :369-377.
  • 4Singh R, Gaiha G, Werncr L, ct al. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection. J Virol, 2011, 85(1) :208-216.
  • 5Ohmine S, Sakuma R, Sakuma T, et al. The antiviral spectra of TRIM5alpha orthologues and human TRIM family proteins against lentiviral production. PLoS One, 2011, 6( 1 ) :e16121.
  • 6Tachado S D, Li X, Swan K, et al. Constitutive activation of phosphatidylinositol 3-kinase signaling pathway down-regulates TLR4-mediated tumor necrosis factor-alpha release in alveolar macrophages from asymptomatic HIV-positive persons in vitro. J Biol Chem, 2008, 283(48):33191-33198.
  • 7Yarilina A, DiCarlo E, Ivashkiv L B. Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs. J Immunol, 2007, 178 (4): 2204-2211.
  • 8Mirandola S R, Hallal D E, Farias A S, et al. Interferon-beta modifies the peripheral blood cell cytokine secretion in patients with multiple sclerosis. Int Immunopharmacol, 2009, 9 ( 7-8 ) : 824-830.
  • 9Carthagena L, Bergamaschi A, Luna J M, et al. Human TRIM gene expression in response to interferons. PLoS One, 2009, 4 (3) :e4894.
  • 10Rajsbaum R, Stoye J P, O'Garra A. Type I interferon-dependent and-independent expression of tripartite motif proteins in immune cells. Eur J Immunol, 2008, 38(3) :619-630.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部